Literature DB >> 10694701

Development of a method for the determination of danofloxacin in plasma by HPLC with fluorescence detection.

M A Garcia1, C Solans, J J Aramayona, S Rueda, M A Bregante.   

Abstract

A simple and sensitive HPLC method has been developed for the determination of danofloxacin (DAN) in plasma. Sample preparations were carried out by adding phosphate buffer (pH 7.4, 0.1 M), followed by extraction with trichloromethane. DAN and the internal standard, sarafloxacin (SAR), were separated on a reversed-phase column, and eluted with aqueous solution-acetonitrile (80:20 v/v). The fluorescence of the column effluent was monitored at lambda(ex) = 338 and lambda(em) = 425 nm. The retention times were 2.80 and 4. 40 min for DAN and SAR, respectively. The method was shown to be linear from 1 to 1500 ng/mL (r(2) = 0.999). The detection and quantitation limit were 1 and 5 ng/mL, respectively. Mean recovery was determined as 80% by the analysis of plasma standards containing 150, 750 and 1500 ng/mL. Inter- and intra-assay precisions were 4.0% and 2.4%, respectively. Copyright 2000 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10694701     DOI: 10.1002/(SICI)1099-0801(200004)14:2<89::AID-BMC931>3.0.CO;2-N

Source DB:  PubMed          Journal:  Biomed Chromatogr        ISSN: 0269-3879            Impact factor:   1.902


  5 in total

1.  Danofloxacin-mesylate is a substrate for ATP-dependent efflux transporters.

Authors:  J A Schrickx; J Fink-Gremmels
Journal:  Br J Pharmacol       Date:  2007-01-08       Impact factor: 8.739

2.  Pharmacokinetic-pharmacodynamic modelling of danofloxacin in turkeys.

Authors:  A M Haritova; N V Rusenova; P R Parvanov; L D Lashev; J Fink-Gremmels
Journal:  Vet Res Commun       Date:  2006-10       Impact factor: 2.459

3.  Susceptibility breakpoint for Danofloxacin against swine Escherichia coli.

Authors:  Yuqi Yang; Yixin Zhang; Jiarui Li; Ping Cheng; Tianshi Xiao; Ishfaq Muhammad; Hongxiao Yu; Ruimeng Liu; Xiuying Zhang
Journal:  BMC Vet Res       Date:  2019-02-04       Impact factor: 2.741

4.  Pharmacokinetics and pharmacodynamics integration of danofloxacin against Eschrichia coli in piglet ileum ultrafiltration probe model.

Authors:  Yuqi Yang; Ping Cheng; Tianshi Xiao; Jargalsaikhan Ulziikhutag; Hongxiao Yu; Jiarui Li; Ruimeng Liu; Ishfaq Muhammad; Xiuying Zhang
Journal:  Sci Rep       Date:  2021-01-12       Impact factor: 4.379

5.  In Vivo Pharmacokinetic/Pharmacodynamic Profiles of Danofloxacin in Rabbits Infected With Salmonella typhimurium After Oral Administration.

Authors:  Xia Xiao; Lin Pei; Li-Jie Jiang; Wei-Xuan Lan; Jia-Yu Xiao; Yon-Jia Jiang; Zhi-Qiang Wang
Journal:  Front Pharmacol       Date:  2018-04-17       Impact factor: 5.810

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.